ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

PURPOSE: Currently, although several clinical trials available give strong suggestions that extension of endocrine therapy has benefits, the risk level at which patients may benefit from extended endocrine therapy remains uncertain. This study aimed to identify the proportion of patients at a substa...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Fangbin, Zhang, Jianbing, Li, Shanbao, Wu, Junyi, Jin, Tao, Qin, Jun, Wang, Ye, Wang, Min, Xu, Junming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633314/
https://www.ncbi.nlm.nih.gov/pubmed/29042797
http://dx.doi.org/10.2147/OTT.S142698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633314/
https://www.ncbi.nlm.nih.gov/pubmed/29042797
http://dx.doi.org/10.2147/OTT.S142698

Ejemplares similares